Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada
· Delayed Price · Currency is CAD 0.500
0.00 (0.00%)
Mar 9, 2026, 2:21 PM EST
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 25.92 million as of March 9, 2026. Its market cap has decreased by -7.67% in one year.
Market Cap
25.92M
Enterprise Value
22.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 25.92M, an increase of 85.72%. That is a compound annual growth rate of 17.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 25.92M | -23.08% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 29.49M |
| Microbix Biosystems | 31.80M |
| Devonian Health Group | 33.19M |
| Defence Therapeutics | 35.57M |
| Quantum BioPharma | 18.21M |
| BriaCell Therapeutics | 37.49M |
| Britannia Life Sciences | 17.85M |
| Resverlogix | 39.49M |